AHK-CU

AHK-Cu, also known as copper tripeptide AHK or Ala-His-Lys-Cu, is a research peptide classified within the skin category. This copper-binding tripeptide represents an enhanced version of the well-known GHK-Cu compound, offering improved stability for extended biological activity in research models. The mechanism of action centres on AHK-Cu's ability to bind copper ions and facilitate their cellular transport. Research indicates this process enhances the activity of enzymes crucial for collagen synthesis and tissue repair pathways. Additionally, studies demonstrate that AHK-Cu modulates gene expression related to skin regeneration and anti-inflammatory responses, making it a valuable tool for dermatological research. In laboratory studies, AHK-Cu has demonstrated several notable effects in research models. Primary findings include stimulation of collagen production, improvements in skin elasticity, enhanced wound healing processes, reduction of inflammatory markers, and promotion of follicular biology. These effects make it particularly relevant for research into skin ageing, wound repair mechanisms, and hair follicle biology. The enhanced stability of AHK-Cu compared to its parent compound GHK-Cu represents a significant advantage for researchers. This improved stability allows for prolonged activity in biological systems, potentially offering more consistent results in experimental designs. Current evidence supporting AHK-Cu research comes primarily from in vitro studies and animal models, with an evidence grade of C. No human clinical trials have specifically evaluated this compound, which limits comprehensive understanding of its full research potential. The available data focuses on skin and hair-related applications, demonstrating promising effects in cellular and animal research models that warrant further investigation in controlled laboratory settings.